[go: up one dir, main page]

WO1996003436A3 - EQUINE η-INTERFERON - Google Patents

EQUINE η-INTERFERON Download PDF

Info

Publication number
WO1996003436A3
WO1996003436A3 PCT/GB1995/001732 GB9501732W WO9603436A3 WO 1996003436 A3 WO1996003436 A3 WO 1996003436A3 GB 9501732 W GB9501732 W GB 9501732W WO 9603436 A3 WO9603436 A3 WO 9603436A3
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
equine
recombinant
polynucleotide fragment
recombinant vector
Prior art date
Application number
PCT/GB1995/001732
Other languages
French (fr)
Other versions
WO1996003436A2 (en
Inventor
David Edward Onions
Lesley Nicholson
Original Assignee
Q One Biotech Ltd
David Edward Onions
Lesley Nicholson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q One Biotech Ltd, David Edward Onions, Lesley Nicholson filed Critical Q One Biotech Ltd
Priority to AU30832/95A priority Critical patent/AU3083295A/en
Publication of WO1996003436A2 publication Critical patent/WO1996003436A2/en
Publication of WO1996003436A3 publication Critical patent/WO1996003436A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides a polynucleotide fragment encoding equine η-interferon, a recombinant vector comprising such a polynucleotide fragment, a host cell containing said polynucleotide fragment or recombinant vector, a recombinant equine η-interferon polypeptide, and pharmaceutical compositions comprising recombinant η-interferon for use as a prophylactic and/or therapeutic agent and also as an adjuvant.
PCT/GB1995/001732 1994-07-21 1995-07-21 EQUINE η-INTERFERON WO1996003436A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30832/95A AU3083295A (en) 1994-07-21 1995-07-24 Equine gamma-interferon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414753A GB2291645A (en) 1994-07-21 1994-07-21 Equine gamma-interferon
GB9414753.5 1994-07-21

Publications (2)

Publication Number Publication Date
WO1996003436A2 WO1996003436A2 (en) 1996-02-08
WO1996003436A3 true WO1996003436A3 (en) 1996-10-03

Family

ID=10758695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001732 WO1996003436A2 (en) 1994-07-21 1995-07-21 EQUINE η-INTERFERON

Country Status (3)

Country Link
AU (1) AU3083295A (en)
GB (1) GB2291645A (en)
WO (1) WO1996003436A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
WO1992003574A1 (en) * 1990-08-13 1992-03-05 The University Of Melbourne Cytokine production
WO1992005255A1 (en) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
EP0271824A2 (en) * 1986-12-10 1988-06-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Horse gamma interferon
WO1992003574A1 (en) * 1990-08-13 1992-03-05 The University Of Melbourne Cytokine production
WO1992005255A1 (en) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CURRAN J.A. ET AL.: "Nucleotide sequence of the equine interferon gamma cDNA", DNA SEQUENCE, vol. 4, no. 6, pages 405 - 407 *
GRÜNIG G. ET AL.: "Cloning and sequencing of horse interferon-gamma cDNA", IMMUNOGENETICS, vol. 39, no. 6, 28 April 1994 (1994-04-28), pages 448 - 449 *
YILMA T. ET AL.: "Preliminary characterization of equine Interferons and their antiviral activities on bovine, ovine and human cells", J. INTERFERON RES., vol. 2, no. 3, pages 363 - 370 *

Also Published As

Publication number Publication date
GB2291645A (en) 1996-01-31
AU3083295A (en) 1996-02-22
WO1996003436A2 (en) 1996-02-08
GB9414753D0 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
WO1996017072A3 (en) Recombinant alphavirus vectors
WO1995007994A3 (en) Recombinant alphavirus vectors
AUPP051497A0 (en) Antimicrobial peptides
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
AU6743294A (en) Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organismstherefor and use thereof
WO1999058562A3 (en) Novel compounds
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
IE830161L (en) Multifunctional cloning vectors
WO1999058683A3 (en) BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
BR0312889A (en) Pegged t20 polypeptide
IL143516A (en) E3 ubiquitin ligase polypeptide, polynucleotide encoding the same and uses thereof
WO1996003435A3 (en) FELINE η-INTERFERON
CA2204151A1 (en) Cdna encoding a bmp type ii receptor
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
WO2000058465A3 (en) Flint polypeptide analogs
WO1996003436A3 (en) EQUINE η-INTERFERON
WO1997005251A3 (en) Feline stem cell factor
EP0911409A3 (en) Deformylase
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
AU4505099A (en) (moraxella catarrahalis) polynucleotides and polypeptides
WO2000070036A3 (en) Genes expressed in hippocampus
CA2088478A1 (en) Cloning and expression of a rhoptry associated protein of p. falciparum
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
AU6833000A (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase